BIOMAT Database Logo BIOMAT Database Logo

Double-blind trial of pirenzepine in acute pancreatitis. 1989

R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Internal Medicine and Digestive Service, Hospital de la Princesa, Autonomous University, Madrid, Spain.

A double-blind clinical trial was carried out to evaluate the efficacy of pirenzepine (PZ) in acute pancreatitis (AP). One hundred and fifteen patients were randomly allocated in three groups, comparable in number, clinical and biochemical parameters. All were hydrated and received nasogastric suction. Group A was the control, groups B and C received additionally 10 and 20 mg of PZ intravenously every 12 h, respectively. PZ-treated patients showed benefit, with a significant difference (p less than 0.01) in the duration of hyperamylasemia and the duration of pain tending to be significantly reduced (p = 0.054). PZ influenced significantly (p less than 0.01) the plasma amylase levels and caused no major adverse effects. Complications were less frequent and mortality was reduced in patients who received PZ. Thus, the use of PZ in AP appears to be beneficial and safe; however, these preliminary results deserve further confirmation before a general recommendation to treat such patients can be made.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Pirenzepine in non-ulcer dyspepsia: a double-blind multicentre trial.
January 1990, The Journal of international medical research,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Indomethacin treatment of acute pancreatitis. A controlled double-blind trial.
September 1985, Scandinavian journal of gastroenterology,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
[Controlled treatment of acute pancreatitis. Double-blind trial with cimetidine].
September 1980, Revista clinica espanola,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Glucagon therapy in acute pancreatitis. Report of a double-blind trial.
March 1978, Gut,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Pirenzepine in non-ulcer dyspepsia. A double-blind, placebo controlled trial.
January 1982, Scandinavian journal of gastroenterology. Supplement,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer.
January 1979, Scandinavian journal of gastroenterology. Supplement,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Treatment of acute pancreatitis with somatostatin: a multicenter double-blind trial.
October 1980, The New England journal of medicine,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Double-blind trial of pirenzepine versus sucralfate in the treatment of endoscopic duodenitis.
January 1990, Clinical therapeutics,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.
May 1978, The British journal of surgery,
R Moreno-Otero, and S Rodriguez, and J Carbó, and L García-Buey, and J M Pajares
Treatment of chronic erosive gastritis: a double-blind trial of pirenzepine and cimetidine.
January 1989, Clinical therapeutics,
Copied contents to your clipboard!